Vanberra Signal

Pixel Therapeutics

Curated by Signal

AI-based risk detection platform for identifying post-traumatic stress disorder

Overview

AI-based risk detection platform for identifying post-traumatic stress disorder. The company offers PixelCare, is a smartphone app that utilizes AI to provide users real-time monitoring, analysis, natural-voice engagement for the purpose of early detection of post-traumatic stress disorder and chronic traumatic encephalopathy.

Key facts

Founded
2018

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of physician services for workplace screening and consumer health

    Health TechnologyKansas City, United States
  • Provider of data analytics and compliance platform for cannabis businesses

    Health TechnologyHobe Sound, United States
  • Provider of cloud-based business intelligence software & hardware solutions for pharmaceutical and biotech sectors

    Health TechnologyWoodstock, United States

About Pixel Therapeutics

What does Pixel Therapeutics do?

AI-based risk detection platform for identifying post-traumatic stress disorder.

Where is Pixel Therapeutics headquartered?

Pixel Therapeutics is headquartered in Burnet, United States.

When was Pixel Therapeutics founded?

Pixel Therapeutics was founded in 2018.

Which sector is Pixel Therapeutics in?

Pixel Therapeutics operates in Health Technology.

Who are Pixel Therapeutics's competitors?

Companies similar to Pixel Therapeutics include Cynergy, Node, and Mosaic.